Andrew S. Plump
President of Research & Development and Representative DirectorDr. Andrew S. Plump, also known as Andy, M.D., Ph.D., serves as President of Research & Development and Representative Director at Takeda Pharmaceutical Company Limited since June 29, 2021. At Takeda Pharmaceutical Company Limited, he also served as President of Research & Development and Director until June 29, 2021, as Chief Medical & Scientific Officer and Director from June 2015, and as Corporate Officer from February 1, 2015 to June 26, 2015. He joined the firm on February 1, 2015. He serves as Director & President of Research & Development of Takeda Ventures, Inc. He serves as a Member of the Board Advisory Council of New York Stock Exchange LLC since May 2020. He also serves on the Board of Directors of the Massachusetts Competitive Partnership and the MIT CEO Advisory Board. Previously, Dr. Plump served as Vice President of Research & Translational Medicine and Deputy to the President of Global R&D at Sanofi, which he joined in July 2012. He spent several years at Merck, where he served as Vice President, Worldwide Cardiovascular Research Head and in a Clinical Pharmacology group. He was also a Howard Hughes postdoctoral fellow at U.C.S.F., where he later served as an Adjunct Clinical Instructor in the department of Medical Genetics. He has a B.S. from Massachusetts Institute of Technology, an M.D. from University of California, and a Ph.D. in Genetics from Rockefeller University. He completed a residency in Internal Medicine and a Fellowship in Medical Genetics at U.C.S.F.
公司職務
- 公司名稱Takeda Pharmaceutical Company Limited股票代碼TAK職務President of Research & Development and Representative Director
